BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9845709)

  • 21. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis.
    Kirklin JK; Brown RN; Huang ST; Naftel DC; Hubbard SM; Rayburn BK; McGiffin DC; Bourge RB; Benza RL; Tallaj JA; Pinderski LJ; Pamboukian SV; George JF; Marques M
    J Heart Lung Transplant; 2006 Mar; 25(3):283-8. PubMed ID: 16507420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
    Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
    J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
    Kobashigawa J; David K; Morris J; Chu AH; Steffen BJ; Gotz VP; Gordon RD
    Transplant Proc; 2005 Mar; 37(2):1333-9. PubMed ID: 15848713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of inhaled cyclosporine in lung-transplant recipients.
    Iacono AT; Johnson BA; Grgurich WF; Youssef JG; Corcoran TE; Seiler DA; Dauber JH; Smaldone GC; Zeevi A; Yousem SA; Fung JJ; Burckart GJ; McCurry KR; Griffith BP
    N Engl J Med; 2006 Jan; 354(2):141-50. PubMed ID: 16407509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
    Barr ML; Baker CJ; Schenkel FA; McLaughlin SN; Stouch BC; Starnes VA; Rose EA
    Clin Transplant; 2000 Apr; 14(2):162-6. PubMed ID: 10770423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of viral genome with graft loss in children after cardiac transplantation.
    Shirali GS; Ni J; Chinnock RE; Johnston JK; Rosenthal GL; Bowles NE; Towbin JA
    N Engl J Med; 2001 May; 344(20):1498-503. PubMed ID: 11357152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal photopheresis as an antirejection prophylaxis in kidney transplant recipients: preliminary results.
    Kusztal M; Kościelska-Kasprzak K; Gdowska W; Zabińska M; Myszka M; Kłak R; Krajewska M; Boratyńska M; Szyber P; Chudoba P; Patrzałek D; Klinger M
    Transplant Proc; 2011 Oct; 43(8):2938-40. PubMed ID: 21996194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation.
    Orrego CM; Cordero-Reyes AM; Estep JD; Loebe M; Torre-Amione G
    J Heart Lung Transplant; 2012 Aug; 31(8):845-9. PubMed ID: 22609184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of traditional versus contemporary immunosuppressive regimens in pediatric heart recipients.
    Marshall CD; Richmond ME; Singh RK; Gilmore L; Beddows K; Chen JM; Addonizio LJ
    J Pediatr; 2013 Jul; 163(1):132-6. PubMed ID: 23391044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression.
    Braunlin EA; Hunter DW; Canter CE; Gutierrez FR; Ring WS; Olivari MT; Titus JL; Spray TL; Bolman RM
    Circulation; 1991 Nov; 84(5 Suppl):III303-9. PubMed ID: 1657452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection.
    Dall'Amico R; Montini G; Murer L; Andreetta B; Zacchello G; Gambino A; Feltrin G; Caforio A; Tursi V; Livi U
    Int J Artif Organs; 2000 Jan; 23(1):49-54. PubMed ID: 12118837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional and novel approaches to immunosuppression.
    Floreth T; Bhorade SM; Ahya VN
    Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of heart transplant rejection with photopheresis.
    Costanzo-Nordin MR; Hubbell EA; O'Sullivan EJ; Johnson MR; Mullen GM; Heroux AL; Kao WG; McManus BM; Pifarre R; Robinson JA
    Transplantation; 1992 Apr; 53(4):808-15. PubMed ID: 1566346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infection and rejection].
    Yagi T; Tanaka N
    Nihon Geka Gakkai Zasshi; 2002 May; 103(5):428-34. PubMed ID: 12048880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection.
    Dall'Amico R; Livi U; Milano A; Montini G; Andreetta B; Murer L; Zacchello G; Thiene G; Casarotto D; Zacchello F
    Transplantation; 1995 Jul; 60(1):45-9. PubMed ID: 7624941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Teszak T; Assabiny A; Kiraly A; Tarjanyi Z; Parazs N; Szakal-Toth Z; Hartyanszky I; Szabolcs Z; Racz K; Reti M; Merkely B; Sax B
    Transpl Immunol; 2023 Aug; 79():101853. PubMed ID: 37196865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.